Skip to main content

Table 3 Baseline plasma EPA and DHA concentration

From: A novel self-micro-emulsifying delivery system (SMEDS) formulation significantly improves the fasting absorption of EPA and DHA from a single dose of an omega-3 ethyl ester concentrate

Study

 

PRF-021 group mean ± SD (μg/mL)

Control group mean ± SD (μg/mL)

 1. Low dose

EPA

21.5 ± 11.2 (N = 20)

25.8 ± 14.6 (N = 20)

DHA

46.1 ± 16.7 (N = 20)

48.1 ± 15.2 (N = 20)

 2. High dose

EPA

23.6 ± 10.4 (N = 39a)

23.7 ± 9.79 (N = 40)

DHA

60.9 ± 18.4 (N = 39a)

61.2 ± 19.8 (N = 40)

  1. aOne subject withdrawn
Back to article page

Lipids in Health and Disease

ISSN: 1476-511X